BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX) header
BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX) profile picture

Life Science investor. Dabble in tech and defense investing. No tweets should be construed as investment advice. Put GOD 1st.

Joined April 2021
Photo by BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX)Photo by BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX)Photo by BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX)Photo by BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX)Photo by BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX)Photo by BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX)Photo by BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX)Photo by BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX)Photo by BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX)Photo by BioMedicalRx 🧬 🇺🇸 ✝️ (@BiomedicalRX)
BioMedicalRx 🧬 🇺🇸 ✝️ retweeted
1/🚨WOW! Intellia Theraputics has just presented clinical data with a follow-up of up to 48 months (!) from its ongoing Phase 1 study of Nex-z / $NTLA - 2001 - Intellia’s CRISPR Cas-9 Gene Editing candidate for the treatment of hereditary ATTR amyloidosis with polyneuropathy (ATTRv-PN). Today’s data demonstrates that a one-time administration of Nex-z led to a deep, consistent and durable reductions of serum TTR in ATTRv-PN patients with mean reductions of 93% from baseline which was sustained through four years of follow-up!
4
7
20
1,666
BioMedicalRx 🧬 🇺🇸 ✝️ retweeted
LEOPOLD ASCHENBRENNER'S SITUATIONAL AWARENESS DISCLOSES NEW POSITION: $300m on BLACK, LOST IMMEDIATELY
18
62
2
2,475
109,179
BioMedicalRx 🧬 🇺🇸 ✝️ retweeted
-4.7sigma move in the last hour in the market 50th worst hour out of the last 17,000
68
93
24
1,853
189,762
Bought the heck out of $SPCX $BE and $NVDA late AH Friday - these buys were on margin so 🤞 here shortly 😅 Buying panic typically does work out very well.
3
775
Imagine not being bullish technology right now… $SPCX $PRME *investors
5
1,008
BioMedicalRx 🧬 🇺🇸 ✝️ retweeted
Here is a recap of one of the best weeks in the CRISPR and Gene Editing space in recent years. $CRSP - positive data from CTX310 phase 1b trail $BEAM - Risto-cel met all of its primary and secondary endpoints $PRME - raised $143.7M via public offering $NTLA - Broad clinical data of lnovo-z presented amid an upcoming FDA approval. $MGX - FDA clearance of Metagenomi’s IND for MGX-001. For those interested in reading more - I have added my own comprehensive post to each one below 👇
1/🚨WOW! CRISPR Therapeutics has presented an updated clinical data from its Phase 1b clinical trial evaluating CTX310 - $CRSP leading In-Vivo CRISPR Cas9 Gene Editing therapy targeting angiopoietin-like protein 3 (ANGPTL3) in patients with severe hypertriglyceridemia (sHTG). The clinical data which was presented at #AHA2026 - the The annual American Heart Association Scientific Sessions, demonstrated that a single administration of CTX310 produced mean reductions from baseline at Day 30 of 65% in circulating ANGPTL3 and 63% in triglycerides (TG) in participants with a median baseline TG level above 1,000 mg/dL. These results show that a single-course treatment with CTX310 can deeply reduce ANGPTL3 and triglycerides in patients with severe hypertriglyceridemia, reinforcing its potential as a one-time “one and done” Gene Editing treatment for sHTG patients.
6
15
2
55
6,627
BioMedicalRx 🧬 🇺🇸 ✝️ retweeted
Amazing! I’m sure that there isn’t a single person on earth who doesn’t feel overwhelmed by today’s tremendous accomplishment. My outmost respect to the SpaceX team and to the most inspiring entrepreneur in our lifetime and the real rocketman - Elon Musk!
1
2
1
13
962
$SPCX sad yet true…
Replying to @BiomedicalRX
99% of people are going to be more worried about what’s going on with Love is Blind than a Engineering feat that changes the trajectory of humanity
4
582
BioMedicalRx 🧬 🇺🇸 ✝️ retweeted
BREAKING: hundreds of NVIDIA employees have signed an internal letter demanding the reinstatement of Jensen Huang as CEO and the resignation of the board
Readers added context they thought people might want to know
Many NVIDIA employees commented in support of bringing back Jensen Huang on an internal suggestion box post, with over 1,600 replies. No reports confirm a signed letter like the one shown. Jensen Huang has resigned as CEO; Colette Kress is interim CEO. wired.com/story/nvidia-e… nvidianews.nvidia.com/news/nvidia-an…
949
1,839
510
16,939
2,383,855
Fine… bought a few $NTLA
Nice update! GL to all $NTLA investors - I don’t get the hate and lack of respect for @intelliatx - no current position but 👀
3
20
1,951
Nice update! GL to all $NTLA investors - I don’t get the hate and lack of respect for @intelliatx - no current position but 👀
1
1
15
3,255
Trading $NVDA aggressively tonight. Already made a nice chunk and now looking to see if 164.5 can break, then ~168 before the bell imo
1
2
605
Long $NVDA at 158. Do I care about the fidelity of a CEO? Chinese spies, maybe. This story is a product of blood in the water. A new rockstar will be hire and life will go on. Picked up more $BE here too.
3
1,237
BioMedicalRx 🧬 🇺🇸 ✝️ retweeted
He HAD to have known. Start the investigation NOW
Well, well, well Rep. Ro Khanna sold $NVDA right before Nvidia's CEO admitted to having a Chinese spy side piece He's a member of the following: - Strategic Competition between the U.S. and the Chinese Communist Party Committee - Taiwan Caucus - High Tech Caucus Apparently, federal agents informed some lawmakers last year that Jensen Huang might be the target of a foreign intelligence operation He avoided a ~26% dip
172
2,558
60
8,687
107,911